Hanall Biopharma Co. on Thursday reported its second-quarter net loss of 3.3 billion won (US$2.4 million), shifting from a profit of 7.3 billion won a year earlier. The company said in a regulatory filing that it posted an operating loss of 3.1 billion won for the April-June period, compared with a profit of 8.1 billion won a year ago. Revenue fell 23.7 percent to 31.6 billion won. Source: Yonhap News Agency
Taiwan Shares Open Higher with Significant Gain
September 7, 2026